COMMUNIQUÉS West-GlobeNewswire

General Oncology Nominated for the 2026 Prix Galien USA Best Startup Award
18/08/2026
Recognition follows preliminary Phase 1 results presented at ESMO Congress 2025 for GO-4 in BRCA/PALB2-mutated stage IV pancreatic ductal adenocarcinoma, where two patients remain progression-free at 48 and 23 months [...]
CHARM Therapeutics announces formation of Clinical Advisory Board to support advancement of CHM-029, its next-generation menin inhibitor
18/08/2026
PRESS RELEASE CHARM Therapeutics announces formation of Clinical Advisory Board to support advancement of CHM-029, its next-generation menin inhibitor LONDON – 18 August 2026 -- CHARM Therapeutics (“CHARM”, “The Company [...]
Immatics Announces Second Quarter 2026 Financial Results and Business Update
18/08/2026
Enrollment in the SUPRAME Phase 3 trial of anzu-cel (anzutresgene autoleucel, IMA203) remains on track to complete the required randomizations by year-end to support final analysis for the primary PFS endpoint; [...]
ABBYY’s New Executive Appointments Illustrate Focus on Hybrid AI to Drive Enterprise Intelligence
18/08/2026
Robert Hucik promoted to Chief Technology Officer and Joe Rayfield hired as SVP of Sales for the Americas and EMEA AUSTIN, Texas, Aug. 18, 2026 (GLOBE NEWSWIRE) -- ABBYY today announced it promoted Robert Hucik to Chief [...]
Tilray Medical Welcomes Progress in Germany’s Medical Cannabis Framework and Supports Continued Policy Development
18/08/2026
As a global medical cannabis leader, Tilray Medical supports continued policy development that strengthens physician confidence, protects patient access and provides a clear, sustainable framework for medical cannabis [...]
Asimov Announces Cell Line Development Partnership with Kaigene to Advance Multispecific Antibody for Autoimmune Disease
18/08/2026
Asimov will use its CHO Edge System to develop a high-titer cell line for Kaigene’s novel multispecific antibody that selectively degrades pathogenic antibodies. BOSTON, Aug. 18, 2026 (GLOBE NEWSWIRE) -- Asimov, the [...]
BlossomHill Therapeutics Announces FDA Fast Track Designation for BH-30643, a Macrocyclic OMNI-EGFR™ Inhibitor for the Treatment of Advanced EGFR C797S-positive NSCLC
18/08/2026
SAN DIEGO, Aug. 18, 2026 (GLOBE NEWSWIRE) -- BlossomHill Therapeutics, Inc. (Nasdaq: BLSM), a clinical-stage biopharmaceutical company applying an intentional, chemistry-based approach to design and develop innovative [...]
Peak Physio Launches Subscription Education Platform Arcane Physio for International Clinician Market
18/08/2026
Physiotherapist Laith Cunneen on Channel 7’s Sunrise. Supplied by Arcane Physio Peak Physio has opened Arcane Physio, a clinical education and reference platform, to external subscribers, targeting physiotherapists [...]
Transactions in connection with share buy-back program
18/08/2026
Company announcement no. 31 - 26 18 August 2026 Transactions in connection with share buy-back program On 4 March 2026 NTG Nordic Transport Group (“NTG”) announced a share buy-back program, as described in company [...]
Smith+Nephew and Imperial College London launch centre to accelerate innovation in surgical robotics
18/08/2026
Marking a new approach to innovation in medical robotics, the new centre will bring advances from a leading surgical robotics research group to patients more quickly Smith+Nephew (LSE:SN, NYSE:SNN), the global medical [...]
Cloud 9 Vets calls on the CMA to add at-home pet euthanasia to the new mandatory vet price list
18/08/2026
Research by the UK in-home veterinary provider found 67% of pet owners had no idea a vet could come to the house to put pets to sleep. Chichester, West Sussex, Aug. 18, 2026 (GLOBE NEWSWIRE) -- Cloud 9 Vets, a national [...]
Coultreon Biopharma Appoints Prista Charuworn, MD as Chief Medical Officer
18/08/2026
Dr. Charuworn’s extensive immunology drug development experience will help accelerate the clinical development of Coultreon’s first-in-class SIK3 inhibitor COL-5671 Leuven, Belgium. August 18, 2026 . Coultreon Biopharma [...]
Coloplast A/S - Interim Financial Report, 9M 2025/26
18/08/2026
Interim financial results, 9M 2025/26 1 October 2025 - 30 June 2026 Coloplast delivered Q3 organic growth of 6% and 5% EBIT growth 1 in constant currencies. Strong quarter in both Chronic Care ex. China and [...]
Basilea reports strong 2026 half-year results and raises full-year guidance; fosmanogepix phase 3 program on track
18/08/2026
Total revenue increases by 14% to CHF 119 million Operating profit increases by 32% to CHF 32 million and net profit by 77% to CHF 28 million Fosmanogepix phase 3 program on track for data readout and regulatory [...]
InnoCare Announces Approval of Head-to-Head Registrational Phase III Trial of Mesutoclax with Azacitidine versus Venetoclax with Azacitidine in Treatment-Naive AML in China
18/08/2026
BEIJING, Aug. 18, 2026 (GLOBE NEWSWIRE) -- InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company focusing on the treatment of cancer and autoimmune diseases, announced today that the Center for [...]
MemoHoney Details Supplement Facts Panel, Serving Directions and Label Information
18/08/2026
Niacin, Calcium, L-Arginine, L-Arginine AKG, L-Citrulline HCl, L-Citrulline Malate and Beta Alanine Combine in a 30-Capsule Memory, Focus and Energy Formula Ogden, UT, Aug. 17, 2026 (GLOBE NEWSWIRE) -- These statements [...]
Coherus Oncology Announces Special Dividend of Biosimilar Contingent Value Rights
17/08/2026
– Entitles holders to receive net proceeds from sale of remaining Legacy Biosimilar Assets – – Completes transformation of Coherus Oncology into a fully integrated, innovative immuno-oncology company – REDWOOD CITY, [...]
ImageneBio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
17/08/2026
SAN DIEGO, Aug. 17, 2026 (GLOBE NEWSWIRE) -- ImageneBio, Inc. (Nasdaq: IMA) (“Imagene” or the “Company”) today announced that on August 14, 2026, the Compensation Committee of the Company’s Board of Directors (the “ [...]
Sagimet Biosciences Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
17/08/2026
FOSTER CITY, Calif., Aug. 17, 2026 (GLOBE NEWSWIRE) -- Sagimet Biosciences Inc. (Nasdaq: SGMT), a clinical-stage biopharmaceutical company developing novel therapeutics targeting dysfunctional metabolic and fibrotic [...]

Pages